Ditran: Difference between revisions

Page 1
Page 2
Content deleted Content added
Citation bot (talk | contribs)
m Citations: [215] added: last1, first1, last2, first2, last3, first3, last4, first4, last5, first5, last6, first6, last7, first7, last8, first8, title, journal, volume, issue, pages, year. Rjwilmsi
Fixed spacing between stub template and category templates
 
(40 intermediate revisions by 26 users not shown)
Line 1: Line 1:
{{Short description|Chemical compound}}
{{drugbox
{{cs1 config|name-list-style=vanc}}
| IUPAC_name = mixture of (1-ethylpyrrolidin-2-yl)methyl 2-cyclopentyl-2-hydroxy-2-phenylacetate and (1-ethylpiperidin-3-yl)-2-cyclopentyl-2-hydroxy-2-phenylacetate
{{Drugbox
| image = Ditran.png
| Verifiedfields = changed
| width = 300
| Watchedfields = changed
| CAS_number = 8015-54-1
| verifiedrevid = 399960637
| ATC_prefix =
| IUPAC_name = mixture of (1-ethylpyrrolidin-2-yl)methyl 2-cyclopentyl-2-hydroxy-2-phenylacetate and (1-ethylpiperidin-3-yl)-2-cyclopentyl-2-hydroxy-2-phenylacetate
| ATC_suffix =
| image = Ditran.svg
| PubChem = 111040
| width = 300
| DrugBank =

| C=20|H=29|N=1|O=3
<!--Clinical data-->
| molecular_weight = 331.448 g/mol
| bioavailability =
| tradename =
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| protein_bound =
| pregnancy_US = <!-- A / B / C / D / X -->
| metabolism =
| pregnancy_category =
| elimination_half-life =
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| excretion =
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
| pregnancy_US = <!-- A / B / C / D / X -->
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
| pregnancy_category=
| legal_US =
| legal_status =
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| routes_of_administration =
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->

| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
<!--Pharmacokinetic data-->
| legal_US =
| bioavailability =
| legal_status =
| protein_bound =
| routes_of_administration =
| metabolism =
| elimination_half-life =
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 8015-54-1
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = US46XLX8YH
| ATC_prefix =
| ATC_suffix =
| PubChem = 111040
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 126644

<!--Chemical data-->
| C=20 | H=29 | N=1 | O=3
}}
}}


'''Ditran''' ('''JB-329''') is an [[anticholinergic]] drug mixture, related to the [[chemical weapons|chemical warfare agent]] [[3-Quinuclidinyl benzilate]] (QNB).
'''Ditran''' ('''JB-329''') is an [[anticholinergic]] drug mixture, related to the [[chemical weapons|chemical warfare agent]] [[3-Quinuclidinyl benzilate]] (QNB).


Ditran is composed of a mixture of 70% 1-ethyl- 2-pyrrolidinylmethyl- alpha- phenylcyclopentylglycolate and 30% 1-ethyl- 3-piperidyl- alpha- phenylcyclopentylglycolate. These compounds are [[structural isomer]]s and have very similar pharmacological properties. The piperidine compound is the more potent of the two and the reason the mixture was used was because of ease of manufacture, however it is also possible to make the piperidine compound in its pure form, so there were ultimately two forms of Ditran used in research, the original 70/30 mix, and "Ditran-B", the pure piperidine compound. Ditran was developed during chemical weapons research in an attempt to produce non-lethal incapacitating agents, similar to QNB itself. The ditran mixture is more potent as an anticholinergic than the piperidyl benzilate drugs such as N- methyl- 3 -piperidyl benzilate, but is less potent than QNB.<ref>Siegfried Franke, Peter Franz and Werner Warnke. Lehrbuch der Militärchemie Bd 1, Militärverlag der Deutschen Demokratischen Republik Ost-Berlin, Deutscher Militärverlag, 1974.</ref><ref>[http://www.nap.edu/openbook.php?record_id=740&page=191 Possible Long-Term Health Effects of Short-Term Exposure to Chemical Agents, Volume 1 (1982). Commission on Life Sciences. The National Academies Press. pp191-195.]</ref>
Ditran is composed of a mixture of 70% 1-ethyl-2-pyrrolidinylmethyl-alpha- phenylcyclopentylglycolate and 30% 1-ethyl-3-piperidyl-alpha-phenylcyclopentylglycolate. These compounds are [[structural isomer]]s and have very similar pharmacological properties. The piperidine compound is the more potent of the two and the reason the mixture was used was because of ease of manufacture, however it is also possible to make the piperidine compound in its pure form, so there were ultimately two forms of Ditran used in research, the original 70/30 mix, and "Ditran-B", the pure piperidine compound. Ditran was developed during chemical weapons research in an attempt to produce non-lethal incapacitating agents, similar to QNB itself. The ditran mixture is more potent as an anticholinergic than the piperidyl benzilate drugs such as N-methyl-3-piperidyl benzilate, but is less potent than QNB.<ref>{{cite book | vauthors = Franke S, Franz P, Warnke W | title = Lehrbuch der Militärchemie | volume = 1 | publisher = Militärverlag der Deutschen Demokratischen Republik | location = Ost-Berlin | year = 1975 | url = https://www.scribd.com/doc/37256308/lehrbuch-der-militarchemie-band-1 }}</ref><ref>{{ cite book | url = http://www.nap.edu/openbook.php?record_id=740&page=191 | title = Possible Long-Term Health Effects of Short-Term Exposure to Chemical Agents | volume = 1 | year = 1982 | author = Commission on Life Sciences | publisher = The National Academies Press | pages = 191–195 | doi = 10.17226/740 | pmid = 25032448 | isbn = 978-0-309-07759-0 }}</ref>


There has been a modest amount of scientific research using this mixture,<ref>{{cite journal | last1 = Volle | first1 = RL | last2 = Alkadhi | first2 = KA | last3 = Branisteanu | first3 = DD | last4 = Reynolds | first4 = LS | last5 = Epstein | first5 = PM | last6 = Smilowitz | first6 = H | last7 = Lambert | first7 = JJ | last8 = Henderson | first8 = EG | title = Ketamine and ditran block end-plate ion conductance and 3Hphencyclidine binding to electric organ membrane | journal = The Journal of pharmacology and experimental therapeutics | volume = 221 | issue = 3 | pages = 570–6 | year = 1982 | pmid = 6123584 }}</ref><ref>{{cite journal | last1 = Vanderwolf | first1 = CH | last2 = Stewart | first2 = DJ | title = Joint cholinergic-serotonergic control of neocortical and hippocampal electrical activity in relation to behavior: effects of scopolamine, ditran, trifluoperazine and amphetamine | journal = Physiology & behavior | volume = 38 | issue = 1 | pages = 57–65 | year = 1986 | pmid = 3786502 }}</ref> but most modern research using these kind of anticholinergic drugs uses N- methyl- 3- piperidyl benzilate due to its wider availability.
There has been a modest amount of scientific research using this mixture,<ref>{{cite journal | vauthors = Volle RL, Alkadhi KA, Branisteanu DD, Reynolds LS, Epstein PM, Smilowitz H, Lambert JJ, Henderson EG | display-authors = 6 | title = Ketamine and ditran block end-plate ion conductance and [3H]phencyclidine binding to electric organ membrane | journal = The Journal of Pharmacology and Experimental Therapeutics | volume = 221 | issue = 3 | pages = 570–6 | date = June 1982 | pmid = 6123584 }}</ref><ref>{{cite journal | vauthors = Vanderwolf CH, Stewart DJ | title = Joint cholinergic-serotonergic control of neocortical and hippocampal electrical activity in relation to behavior: effects of scopolamine, ditran, trifluoperazine and amphetamine | journal = Physiology & Behavior | volume = 38 | issue = 1 | pages = 57–65 | year = 1986 | pmid = 3786502 | doi = 10.1016/0031-9384(86)90132-0 | s2cid = 35451507 }}</ref> but most modern research using these kinds of anticholinergic drugs uses N-methyl-3-piperidyl benzilate due to its wider availability.


== See also ==
== See also ==
* [[N-methyl-3-piperidyl benzilate]]
* [[N-Methyl-3-piperidyl benzilate]]
* [[N-ethyl-3-piperidyl benzilate]]
* [[N-Ethyl-3-piperidyl benzilate]]
* [[3-Quinuclidinyl benzilate]]
* [[3-Quinuclidinyl benzilate]]
* [[EA-3167]]
* [[EA-3167]]


== References ==
== References ==
{{Reflist|2}}
{{Reflist}}

== External links ==
*{{Commonscat-inline}}


{{Hallucinogens}}
{{Hallucinogens}}
{{Muscarinic acetylcholine receptor modulators}}
{{Cholinergics}}


[[Category:Deliriants]]
[[Category:Deliriants]]
[[Category:Anticholinergics]]
[[Category:Muscarinic antagonists]]
[[Category:Pyrrolidines]]
[[Category:Pyrrolidines]]
[[Category:Piperidines]]
[[Category:Piperidines]]
[[Category:Carboxylate esters]]
[[Category:Acetate esters]]
[[Category:Tertiary alcohols]]
[[Category:Phenylcyclopentylglycolate esters]]




{{hallucinogen-stub}}
{{hallucinogen-stub}}

[[pl:Ditran]]